跳至主要内容
临床试验/NCT05124496
NCT05124496暂停不适用

Validation of the HyperDetector Digital Solution Screening Assay for Rapid Screening for Potential SARS-CoV-2 (COVID-19) Infection

HyperSpectral APD1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2020年12月11日最近更新:
适应症

试验速览

阶段
不适用
状态
暂停
发起方
入组人数
10,000
试验地点
1
主要终点
Specificity

研究概览

简要总结

To evaluate the HyperDetector as a method to rapidly screen SARS-CoV-2

To determine the sensitivity and specificity of the screening assay performed on oral swab and saliva specimens, compared to a validated RT-PCR COVID-19 method using nasal or nasopharyngeal swabs and to separately collected nasal swabs, oral swabs, oral rinse and saliva samples.

To determine the best workflow for using such an assay to reflex suspicious/positive samples to a validated RT-PCR COVID-19 assay.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
5 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •Subjects at COVID-19 testing site for Rt-PCR test.

排除标准

  • •Minors under the age of 5

结局指标

主要结局

Specificity

时间窗: By 12/30/2022

To determine the specificity of the screening assay

Sensitivity

时间窗: By 12/30/2022

To determine the sensitivity of the screening assay

次要结局

未报告次要终点

研究者

发起方
HyperSpectral APD
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验